TF1 – Global Health and Covid-19
BOOSTING EQUITABLE ACCESS AND PRODUCTION OF DIAGNOSTICS, THERAPEUTICS AND VACCINES TO CONFRONT COVID-19 ON A GLOBAL FOOTING
ABSTRACT
The COVID-19 pandemic has demonstrated the devastating impact of a large-scale disease on global health and wellbeing, security and economies. It has also shown the importance of reliable preparedness systems, and international collaboration and co-ordination among diverse stakeholders. G20 leaders are actively encouraged to build on the lessons learned from the pandemic. These include: ensuring worldwide equitable access to tests, vaccines and treatments for COVID-19 and beyond; the importance of not leaving low and middle income countries (LMICs) behind; and ensuring resilient supply chains through new and more robust manufacturing policies and capacities.
AUTHORS
Lieve Fransen
European Policy Centre; and Wits University
John Nkengason
African Centers for Disease Control and Prevention
Smita Srinivas
Co-Chair T20 Italy Task Force on Global Health and Covid-19; Open University; National Centre for Biological Sciences TIFR-NCBS; and University College London
Stefano Vella
Co-Chair T20 Italy Task Force on Global Health and Covid-19; and Università Cattolica del Sacro Cuore